ENOV · Enovis Corp
United States · RS rating 38 · As of 2026-11-03
| Price | 20.89 USD |
|---|---|
| 1-day change | +1.3% |
| RS rating (overall / 1M / 3M / 12M) | 38 / 85 / 20 / 29 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 10 / 27 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +8.9% |
| Sales growth Q/Q | +4.9% |
| Distance from 52-week high | +33.7% |
| Market cap (USD) | $1.3B |